SELLAS Life Sciences Group, Inc. (SLS)
Since May 20, 2008, SELLAS Life Sciences Group, Inc. (SLS) has reported earnings 69 times. On average the shares move ±6.29% post-earnings, with a positive reaction 39.1% of the time. Its largest post-earnings gain was +25% (May 12, 2026) and its largest decline was -43.96% (Nov 14, 2022). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings reactions
How SLS moved on each past earnings report.
Earnings Impact
Total Earnings
69
Avg Abs. Movement
±6.29%
Positive %
39.1%
Negative %
60.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 12, 2026 | ☽ POST | +25% | open_in_new |
| Mar 19, 2026 | ☽ POST | -8.46% | open_in_new |
| Nov 12, 2025 | ☽ POST | -2.01% | open_in_new |
| Aug 12, 2025 | ☽ POST | -3.73% | open_in_new |
Earnings Count
69
Total earnings in dataset
Avg Abs. Movement
±6.29%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260625 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 8-K | 20260618 | open_in_new SEC.gov |
| S-8 | 20260616 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260424 | open_in_new SEC.gov |
| ARS | 20260423 | open_in_new SEC.gov |
| DEFA14A | 20260423 | open_in_new SEC.gov |
| DEF 14A | 20260423 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260327 | open_in_new SEC.gov |
Frequently asked about SLS earnings
When does SELLAS Life Sciences Group, Inc. report earnings next? expand_more
SELLAS Life Sciences Group, Inc. (SLS)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SLS stock move after earnings? expand_more
Over 69 reports, SLS has moved an average of ±6.29% the session after earnings, closing higher 39.1% of the time.
What was SLS's biggest post-earnings move? expand_more
SLS's largest post-earnings gain on record was +25% on May 12, 2026, and its largest decline was -43.96% on Nov 14, 2022.
Where can I find SELLAS Life Sciences Group, Inc.'s SEC filings? expand_more
All of SELLAS Life Sciences Group, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right